Skip to content

Toxicological Screening with LC-MS/MS in critically ill patients

Toxicological Screening with LC-MS/MS in critically ill patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024762
Enrollment
50
Registered
2021-03-11
Start date
2021-03-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F10-F19

Interventions

Group 1: In patients with intoxication or coma of unknown cause requiring intensive care medicine, a blood and urine test is carried out for further toxicological screening at the time of their admiss

Sponsors

Allgemeine Intensivstation Universitätsklinik für Innere Medizin Medizinische Universität Graz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Suspected intoxication or coma of unknown etiology - need for intensive care medicine - adult

Exclusion criteria

Exclusion criteria: - anuria - Missing substance detection in the LC-MS / MS in the urine

Design outcomes

Primary

MeasureTime frame
Would the presence of the LC-MS / MS results in the urine have changed the initial clinical diagnosis?

Secondary

MeasureTime frame
1. Would the existence of the exact substance identification have influenced the diagnostic and / or the treatment in the acute situation? 2. Can the severity of poisoning be determined on the basis of the semi-quantitative LC-MS / MS results in the serum? 3. Would the additional presence of the active substance concentration in the serum have influenced the diagnostic and / or the treatment in the acute situation?

Countries

Austria

Contacts

Public ContactGerald Hackl

Allgemeine Intensivstation Universitätsklinik für Innere Medizin Medizinische Universität Graz

gerald.hackl@medunigraz.at004331638580698

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026